- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有260家主力机构披露2025-06-30报告期持股数据，持仓量总计2.70亿股，占流通A股62.71%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为28.38元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"28.38","date":1760864854,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。
[{"date":"2025.10.20","stock":"0.53","trade":"0.20","ind":"0.63"},{"date":"2025.10.17","stock":"-2.10","trade":"-0.94","ind":"-1.95"},{"date":"2025.10.16","stock":"2.36","trade":"0.75","ind":"0.10"},{"date":"2025.10.15","stock":"0.46","trade":"1.37","ind":"1.22"},{"date":"2025.10.14","stock":"1.77","trade":"0.32","ind":"-0.62"},{"date":"2025.10.13","stock":"-0.32","trade":"-0.86","ind":"-0.19"},{"date":"2025.10.10","stock":"2.96","trade":"1.31","ind":"-0.94"},{"date":"2025.10.09","stock":"2.12","trade":"0.26","ind":"1.32"},{"date":"2025.09.30","stock":"0.27","trade":"0.12","ind":"0.52"},{"date":"2025.09.29","stock":"-0.19","trade":"0.13","ind":"0.90"},{"date":"2025.09.26","stock":"0.49","trade":"-0.51","ind":"-0.65"},{"date":"2025.09.25","stock":"-2.16","trade":"-0.70","ind":"-0.01"},{"date":"2025.09.24","stock":"0.37","trade":"1.12","ind":"0.83"},{"date":"2025.09.23","stock":"-1.65","trade":"-1.40","ind":"-0.18"},{"date":"2025.09.22","stock":"1.76","trade":"-0.53","ind":"0.22"},{"date":"2025.09.19","stock":"0.49","trade":"-1.04","ind":"-0.30"},{"date":"2025.09.18","stock":"-0.19","trade":"-1.21","ind":"-1.15"},{"date":"2025.09.17","stock":"0.26","trade":"-0.25","ind":"0.37"},{"date":"2025.09.16","stock":"0.00","trade":"0.68","ind":"0.04"},{"date":"2025.09.15","stock":"-1.44","trade":"-0.41","ind":"-0.26"},{"date":"2025.09.12","stock":"-1.06","trade":"-0.31","ind":"-0.12"}]
马应龙,上证指数,中药指数
压力支撑
该股压力位为28.32元，支撑位为28.02元。
[{"text":"\u538b\u529b\u4f4d","value":"28.32","date":1760889600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"28.02","date":1760889600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.5资金面打败了83%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体无进出。
更新时间：10月20日 20:38
| 机构今日流向(万元) | -846.51 | 机构5日流向(万元) | -85.69 |
| 机构10日流向(万元) | -988.96 | 机构20日流向(万元) | -16501.46 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加905.54万股，其中基金净减仓31家，主力净增仓18家，请投资者中长期谨慎为宜。
截止2025-06-30，共260家主力机构（基金254家，一般法人3家，社保基金1家，QFII2家），持仓量总计26983.04万股，占流通A股62.71%
其中，基金持仓与2024-12-31相比：
增仓：27家 ，增持 1665.74万股
减仓：58家 ，减持 1647.60万股
新出现在主力名单中：156家 ，持有3827.24万股
从主力名单中消失：138家 ，原持有3252.05万股
其中，基金持仓与2024-12-31相比：
增仓：27家 ，增持 1665.74万股
减仓：58家 ，减持 1647.60万股
新出现在主力名单中：156家 ，持有3827.24万股
从主力名单中消失：138家 ，原持有3252.05万股
消息面诊股
诊断结果：6.3消息面打败了91%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 马应龙：10月17日持仓该股ETF资金净流入304
2025-10-20 - 马应龙：10月17日获融资买入2662.63万元
2025-10-18 - 行业周报|中药指数涨0.63%, 跑赢上证指数2.
2025-10-17 - 马应龙：10月16日获融资买入3442.04万元
2025-10-17 - 马应龙：10月15日获融资买入1150.35万元
2025-10-16 - 马应龙：10月14日获融资买入1329.06万元
2025-10-15 - 马应龙：10月13日获融资买入1488.53万元
2025-10-14 - 马应龙：10月10日获融资买入1927.62万元
2025-10-11 - 马应龙：10月9日持仓该股ETF资金净流入55.1
2025-10-10 - 马应龙：10月9日获融资买入1950.26万元
2025-10-10
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-06-10 |
| 利好 | 分红转增 | 10派6.20元(含税) | 2025-04-03 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 高管变动 | 因工作变动 | 2024-12-02 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-19 |
| 一般消息 | 高管变动 | 因退休原因 | 2024-11-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-25 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.5行业面打败了94%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2025.10.20","price":"0.63","value":"0.20"},{"date":"2025.10.17","price":"-1.95","value":"-0.94"},{"date":"2025.10.16","price":"0.10","value":"0.75"},{"date":"2025.10.15","price":"1.22","value":"1.37"},{"date":"2025.10.14","price":"-0.62","value":"0.32"},{"date":"2025.10.13","price":"-0.19","value":"-0.86"},{"date":"2025.10.10","price":"-0.94","value":"1.31"},{"date":"2025.10.09","price":"1.32","value":"0.26"},{"date":"2025.09.30","price":"0.52","value":"0.12"},{"date":"2025.09.29","price":"0.90","value":"0.13"},{"date":"2025.09.26","price":"-0.65","value":"-0.51"},{"date":"2025.09.25","price":"-0.01","value":"-0.70"},{"date":"2025.09.24","price":"0.83","value":"1.12"},{"date":"2025.09.23","price":"-0.18","value":"-1.40"},{"date":"2025.09.22","price":"0.22","value":"-0.53"},{"date":"2025.09.19","price":"-0.30","value":"-1.04"},{"date":"2025.09.18","price":"-1.15","value":"-1.21"},{"date":"2025.09.17","price":"0.37","value":"-0.25"},{"date":"2025.09.16","price":"0.04","value":"0.68"},{"date":"2025.09.15","price":"-0.26","value":"-0.41"},{"date":"2025.09.12","price":"-0.12","value":"-0.31"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 49.03% | 6.60% | 6.4分 |
| 2 | 方盛制药 | 11.11% | 3.45% | 6.5分 |
| 3 | 维康药业 | 7.02% | 3.91% | 4.9分 |
| 4 | 吉林敖东 | 5.84% | -0.29% | 5.8分 |
| 5 | 马应龙 | 5.74% | 2.99% | 6.8分 |
| 6 | 特一药业 | 5.42% | 6.50% | 6.8分 |
| 8 | 金花股份 | 5.08% | 5.23% | 6.7分 |
| 10 | 贵州百灵 | 3.71% | 15.82% | 6.0分 |
| 12 | 佐力药业 | 0.98% | 0.33% | 5.9分 |
| 14 | 江中药业 | 0.65% | 0.61% | 6.3分 |
| 16 | 益盛药业 | -0.62% | 2.44% | 5.6分 |
| 18 | 以岭药业 | -0.70% | 6.55% | 6.8分 |
| 20 | 昆药集团 | -0.77% | 1.28% | 5.8分 |
| 22 | 达仁堂 | -0.86% | 6.01% | 6.7分 |
| 24 | 嘉应制药 | -1.24% | -1.55% | 5.9分 |
| 26 | 桂林三金 | -1.33% | 0.95% | 6.4分 |
| 28 | 莱茵生物 | -1.40% | 0.13% | 5.7分 |
| 30 | ST香雪 | -1.61% | -0.27% | 4.4分 |
| 32 | 亚宝药业 | -1.87% | 2.87% | 6.2分 |
| 34 | 华润三九 | -2.27% | -0.25% | 6.0分 |
| 36 | 益佰制药 | -2.31% | 2.18% | 6.1分 |
| 38 | 葵花药业 | -2.42% | 0.39% | 4.9分 |
| 40 | 太龙药业 | -2.71% | -2.57% | 5.5分 |
| 42 | 贵州三力 | -2.95% | 1.13% | 5.4分 |
| 44 | 奇正藏药 | -3.26% | 1.11% | 6.3分 |
| 46 | 同仁堂 | -3.30% | -0.29% | 5.3分 |
| 48 | 红日药业 | -3.35% | 1.35% | 6.1分 |
| 50 | 仁和药业 | -3.74% | 0.98% | 5.9分 |
| 52 | 珍宝岛 | -4.10% | -1.26% | 5.6分 |
| 54 | 沃华医药 | -4.83% | -0.79% | 6.3分 |
| 56 | 新光药业 | -4.92% | 2.26% | 5.8分 |
| 58 | 步长制药 | -5.27% | -0.45% | 5.4分 |
| 60 | *ST长药 | -6.78% | 0.79% | 4.2分 |
| 62 | 片仔癀 | -7.31% | -3.55% | 5.1分 |
| 64 | 启迪药业 | -8.82% | -0.27% | 4.6分 |
| 66 | 恩威医药 | -10.32% | -0.90% | 4.9分 |
| 68 | 九芝堂 | -10.83% | -0.31% | 5.2分 |
| 70 | 振东制药 | -11.50% | 0.59% | 5.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 13/110 ， 42/110。
[{"date":"2025-06-30","value":"8.36","vol":"3.94"},{"date":"2025-03-31","value":"4.88","vol":"2.20"},{"date":"2024-12-31","value":"13.53","vol":"4.81"},{"date":"2024-09-30","value":"11.82","vol":"2.92"},{"date":"2024-06-30","value":"8.22","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
8.36 | 4.88 | 13.53 | 11.82 | 8.22 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"49.58","vol":"52.43"},{"date":"2025-03-31","value":"49.89","vol":"52.92"},{"date":"2024-12-31","value":"46.55","vol":"52.40"},{"date":"2024-09-30","value":"47.77","vol":"52.75"},{"date":"2024-06-30","value":"48.35","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
49.58 | 49.89 | 46.55 | 47.77 | 48.35 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 23/110 ， 26/110。
[{"date":"2025-06-30","value":"1.11","vol":"-6.98"},{"date":"2025-03-31","value":"1.48","vol":"-6.63"},{"date":"2024-12-31","value":"18.85","vol":"-6.97"},{"date":"2024-09-30","value":"14.13","vol":"-4.57"},{"date":"2024-06-30","value":"17.52","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.11 | 1.48 | 18.85 | 14.13 | 17.52 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"10.04","vol":"2.33"},{"date":"2025-03-31","value":"2.99","vol":"-36.42"},{"date":"2024-12-31","value":"19.14","vol":"-142.71"},{"date":"2024-09-30","value":"9.35","vol":"63.06"},{"date":"2024-06-30","value":"10.85","vol":"-13.80"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
10.04 | 2.99 | 19.14 | 9.35 | 10.85 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.80 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/110 ， 1/110。
[{"date":"2025-06-30","value":"0.36","vol":"0.24"},{"date":"2025-03-31","value":"0.18","vol":"0.12"},{"date":"2024-12-31","value":"0.74","vol":"0.49"},{"date":"2024-09-30","value":"0.56","vol":"0.37"},{"date":"2024-06-30","value":"0.38","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.36 | 0.18 | 0.74 | 0.56 | 0.38 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.52","vol":"1.17"},{"date":"2025-03-31","value":"1.77","vol":"0.60"},{"date":"2024-12-31","value":"7.23","vol":"2.40"},{"date":"2024-09-30","value":"4.95","vol":"1.79"},{"date":"2024-06-30","value":"3.52","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.52 | 1.77 | 7.23 | 4.95 | 3.52 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 37/110 ， 47/110。
[{"date":"2025-06-30","value":"16.05","vol":"20.17"},{"date":"2025-03-31","value":"15.82","vol":"0.38"},{"date":"2024-12-31","value":"19.26","vol":"15.45"},{"date":"2024-09-30","value":"10.66","vol":"6.15"},{"date":"2024-06-30","value":"17.04","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 16.05 | 15.82 | 19.26 | 10.66 | 17.04 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.20","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.35","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"2.10","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.20 | - | 2.35 | - | 2.10 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 49/110 ， 56/110。
[{"date":"2025-06-30","value":"3.35","vol":"2.88"},{"date":"2025-03-31","value":"4.60","vol":"2.97"},{"date":"2024-12-31","value":"4.94","vol":"2.86"},{"date":"2024-09-30","value":"4.78","vol":"3.22"},{"date":"2024-06-30","value":"4.37","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.35 | 4.60 | 4.94 | 4.78 | 4.37 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"3.04","vol":"2.11"},{"date":"2025-03-31","value":"4.21","vol":"2.20"},{"date":"2024-12-31","value":"4.51","vol":"2.09"},{"date":"2024-09-30","value":"4.28","vol":"2.40"},{"date":"2024-06-30","value":"3.95","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.04 | 4.21 | 4.51 | 4.28 | 3.95 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 41/110 ， 43/110。
[{"date":"2025-06-30","value":"24.19","vol":"33.91"},{"date":"2025-03-31","value":"19.03","vol":"33.34"},{"date":"2024-12-31","value":"18.92","vol":"34.08"},{"date":"2024-09-30","value":"19.40","vol":"32.93"},{"date":"2024-06-30","value":"23.32","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
24.19 | 19.03 | 18.92 | 19.40 | 23.32 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.33","vol":"0.74"},{"date":"2025-03-31","value":"0.24","vol":"0.72"},{"date":"2024-12-31","value":"0.24","vol":"0.74"},{"date":"2024-09-30","value":"0.25","vol":"3.16"},{"date":"2024-06-30","value":"0.31","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.33 | 0.24 | 0.24 | 0.25 | 0.31 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 招商证券 | 2025-09-14 | 增持 | |
| 长江证券 | 2025-09-09 | 买入 | |
| 华源证券 | 2025-09-03 | 买入 | |
| 中信证券 | 2025-09-02 | 买入 | |
| 国海证券 | 2025-08-29 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"4.65","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.79","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.43","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.28","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.38","blueLineValue":"1.48","type":"YC"}]